Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
111. |
ECCT/14/04/01 | REACH Trial REALIZING EFFECTIVENESS ACROSS CONTINENTS WITH HYDROXYUREA (REACH): A PHASE I/II PILOT STUDY OF HYDROXYUREA FOR CHILDREN WITH SICKLE CELL ANAEMIA. |
Principal Investigator(s) 1. Thomas Neil Williams Site(s) in Kenya Kilifi County Hospital |
View |
112. |
ECCT/13/04/03 | HIV-Malaria Study_A5297 An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of Plasmodium falciparum Subclinical Parasitemia in HIV-infected Adults with CD4+ Counts >200 and <350 cells/mm3 . |
Principal Investigator(s) 1. Josphat K. Kosgei Site(s) in Kenya 1. Kemri Walter Reed Project-Kericho (Kericho county) 2. Moi University Clinical Research Centre (Uasin Gishu county) |
View |
113. |
ECCT/13/02/01 | AMC 068 A Randomized Phase II Trial Of Chop Vs Oral Chemotherapy with Concomitant Antiretroviral Therapy in Patients with HIV-Associated Lymphoma in Sub-Saharan Africa |
Principal Investigator(s) 1. NAFTALI WISINDI BUSAKHALA Site(s) in Kenya MOI UNIVERSITY CLINICAL RESEARCH CENTER |
View |
114. |
ECCT/13/01/01 | An Open Label Randomized Controlled Phase IIb Trial to Determine the Safety of Oral Fluconazole in Combination with Flucytosine as Compared to Fluconazole Alone |
Principal Investigator(s) 1. Ana-Claire Meyer 2. Judith Kwasa 3. Mark Jacobson Site(s) in Kenya 1. Family AIDS Care and Education Services, Lumumba Health Center (Kisumu county) 2. Family AIDS Care and Education Services, Suba District Hospital (Homa Bay county) |
View |
115. |
ECCT/12/11/03 | Rifampin-Based TB Treatment vs. Rifabutin-Based TB Treatment in HIV A5290 "A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifampin-Based Tuberculosis Treatment versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifabutin-Based Tuberculosis Treatment with or without Raltegravir in HIV-1-Infected Persons Requiring Treatment for Active TB and HIV" |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) |
View |